United States · Bill · S
S. 2527 (106th)
Drug Treatment and Research Enhancement Act
Introduced
9 May 2000
Last action
9 May 2000 · Introduced
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
Chuck Grassley, Rep. Cochran, Thad [R-MS-4], Rep. DeWine, Mike [R-OH-7]
Subjects
Healthcare, Education
Source updated
20 August 2025
Summary
Drug Treatment and Research Enhancement Act - Directs the Attorney General to award a grant to the Parents Collaboration to conduct a national campaign to help parents and families prevent drug abuse by children. Authorizes the Director of the Office of National Drug Control Policy to award a grant to establish a National Community Antidrug Coalition Institute to provide antidrug education, training, and technical assistance to coalition leaders and community teams, to conduct related research and testing, and to translate knowledge from research into practical information. Key Professionals Education Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services to award grants to help key professionals participate in antidrug coalitions to identify and help youth affected by familial substance abuse. Requires the Director of the National Institute on Drug Abuse to establish a National Drug Abuse Treatment Clinical Trials Network to conduct large-scale drug abuse treatment studies. Adolescent Therapeutic Community Treatment Programs Act - Directs the Secretary to award competitive grants to enable treatment providers who administer substance abuse treatment programs to establish adolescent residential substance abuse treatment programs for individuals between 14 and 21 years old. Requires the Director of the Federal Bureau of Prisons to establish residential drug abuse treatment units in Federal prisons. Extends through FY 2007 the drug-free communities support program. Directs the Counter-Drug Technology Assessment Center to study the number of individuals engaged in sustained heroin use. Establishes 4000 as the minimum (currently, the maximum) number of members of the National Guard that shall be on duty at year's end to perform drug interdiction or counter-drug activities. Expresses the sense of Congress that the National Institutes of Health should work with private industry to promote research regarding pharmacological options to support drug treatment efforts. Authorizes appropriations.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 May 2000
Introduced
Introduced in Senate
Source: IntroReferral
9 May 2000
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
9 May 2000
Introduced
Sponsor introductory remarks on measure. (CR S3735-3736)
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 9 May 2000 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 9 May 2000
Introduced in Senate (PDF)
Introduced in Senate · EN · 9 May 2000
Introduced in Senate
summary · EN · 9 May 2000
Sponsors
- Chuck Grassley · R · Sponsor
- Rep. Cochran, Thad [R-MS-4] · R · Cosponsor
- Rep. DeWine, Mike [R-OH-7] · R · Cosponsor
- · sshr00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/106th-congress/senate-bill/2527
- Open data entity: https://api.congress.gov/v3/bill/106/s/2527
- us · 106-s-2527 · source updated 20 August 2025